Clinical Trials Browser

Phase 2 × OTHER_GOV × Peritoneal Neoplasms × Clear all

NCT04475159 2020-07-17

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Phase 2 Unknown

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms